IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 3.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,709,000 | +0.6% | 1,472,753 | +15.4% | 0.00% | 0.0% |
| Q4 2017 | $2,692,000 | +20.9% | 1,276,263 | +27.8% | 0.00% | 0.0% |
| Q3 2017 | $2,227,000 | +31.7% | 998,697 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $1,691,000 | -25.5% | 983,244 | +6.9% | 0.00% | 0.0% |
| Q1 2017 | $2,271,000 | +74.6% | 919,446 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $1,301,000 | -29.1% | 867,504 | +21.1% | 0.00% | 0.0% |
| Q3 2016 | $1,834,000 | +73.7% | 716,449 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $1,056,000 | -21.5% | 690,206 | +1.5% | 0.00% | 0.0% |
| Q1 2016 | $1,346,000 | -35.5% | 680,280 | +0.6% | 0.00% | 0.0% |
| Q4 2015 | $2,088,000 | +1.2% | 676,017 | +9.7% | 0.00% | 0.0% |
| Q3 2015 | $2,063,000 | -3.2% | 616,034 | +7.2% | 0.00% | 0.0% |
| Q2 2015 | $2,132,000 | +6.0% | 574,675 | +6.0% | 0.00% | 0.0% |
| Q1 2015 | $2,011,000 | +3.6% | 542,277 | +23.2% | 0.00% | 0.0% |
| Q4 2014 | $1,941,000 | +98.3% | 440,211 | +3.0% | 0.00% | 0.0% |
| Q3 2014 | $979,000 | -9.6% | 427,570 | +14.5% | 0.00% | 0.0% |
| Q2 2014 | $1,083,000 | -19.7% | 373,463 | +12.9% | 0.00% | 0.0% |
| Q1 2014 | $1,349,000 | +10.8% | 330,770 | +25.7% | 0.00% | 0.0% |
| Q4 2013 | $1,218,000 | +314.3% | 263,234 | +56.0% | 0.00% | – |
| Q3 2013 | $294,000 | +167.3% | 168,741 | +0.1% | 0.00% | – |
| Q2 2013 | $110,000 | – | 168,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|